You need to enable JavaScript to run this app.
FDA proposes waiving GDUFA facility fees for domestic manufacturers
Regulatory News
Joanne S. Eglovitch
GDUFA
Generics
Manufacturing
Regulatory Intelligence/Policy
United States
US Food and Drug Administration (FDA)